1-[[4-[2-(氮杂环庚烷-1-基)乙氧基]苯基]甲基]-2-(4-羟基苯基)-3-甲基-吲哚-5-醇

• 常用名: 1-[[4-[2-(氮杂环庚烷-1-基)乙氧基]苯基]甲基]-2-(4-羟基苯基)-3-甲基-吲哚-5-醇
• 英文名: Bazedoxifene
• CAS号: 198481-32-2
• 分子量: 470.603
• 密度: 1.2±0.1 g/cm3
• 沸点: 694.4±55.0 °C at 760 mmHg
• 分子式: C₃₀H₃₄N₂O₃
• 熔点: N/A
• 闪点: 373.8±31.5 °C

用途

Bazedoxifene是雌激素受体调节剂(SERM)。

名称

• 中文名: 1-[[4-[2-(氮杂环庚烷-1-基)乙氧基]苯基]甲基]-2-(4-羟基苯基)-3-甲基-吲哚-5-醇
• 英文名: 1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methylindol-5-ol
• 中文别名: 巴多昔芬

生物活性

• 描述: Bazedoxifene是雌激素受体调节剂(SERM)。
• 相关类别:
  信号通路 >> 其他 >> 雌激素受体/ERR
  研究领域 >> 癌症
• 参考文献:

  [1]. Lewis-Wambi JS, et al. The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1. Mol Pharmacol. 2011 Oct;80(4):610-20.

  [2]. Duggan ST, McKeage K. Bazedoxifene: a review of its use in the treatment of postmenopausal osteoporosis. Drugs. 2011 Nov 12;71(16):2193-212.

  [3]. Lello S, Brandi ML, Minisola G et al. Bazedoxifene: literature data and clinical evidence. Clin Cases Miner Bone Metab. 2011 Sep;8(3):29-32.

  [4]. Komm BS, Chines AA. Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis. Ther Adv Musculoskelet Dis. 2012 Feb;4(1):21-34.

物理化学性质

• 密度: 1.2±0.1 g/cm3
• 沸点: 694.4±55.0 °C at 760 mmHg
• 分子式: C₃₀H₃₄N₂O₃
• 分子量: 470.603
• 闪点: 373.8±31.5 °C
• 精确质量: 470.256958
• PSA: 57.86000
• LogP: 6.59
• 蒸汽压: 0.0±2.3 mmHg at 25°C
• 折射率: 1.622
• 储存条件: 2-8℃

英文别名

• TSE-424
• Bazedoxifene
• 1H-Indol-5-ol, 1-[[4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-
• 1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-indol-5-ol
• 1-{4-[2-(Azepan-1-yl)ethoxy]benzyl}-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol
• Bazedoxifeno
• 1-{4-[2-(1-Azepanyl)ethoxy]benzyl}-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol
• 1H-Indol-5-ol, 1-((4-(2-(hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-
• Conbriza